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Mutations in the MESP2 Gene Cause
Spondylothoracic Dysostosis/Jarcho-Levin Syndrome
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Simon E. Carlo,1,8 Jose Torres,2 John B. Emans,5 Peter D. Turnpenny,9 and Olivier Pourquie´10,*
Spondylothoracic dysostosis (STD), also known as Jarcho-Levin syndrome (JLS), is an autosomal-recessive disorder characterized by
abnormal vertebral segmentation and defects affecting spine formation, with complete bilateral fusion of the ribs at the costovertebral
junction producing a ‘‘crab-like’’ conﬁguration of the thorax. The shortened spine and trunk can severely affect respiratory function dur-
ing early childhood. The condition is prevalent in the Puerto Rican population, although it is a panethnic disorder. By sequencing a set of
candidate genes involved in mouse segmentation, we identiﬁed a recessive E103X nonsense mutation in themesoderm posterior 2 homo-
log (MESP2) gene in a patient, of Puerto Rican origin and from the Boston area, who had been diagnosed with STD/JLS.We then analyzed
12 Puerto Rican families with STD probands for the MESP2 E103X mutation. Ten patients were homozygous for the E103X mutation,
three patients were compound heterozygous for a second nonsense mutation, E230X, or a missense mutation, L125V, which affects
a conserved leucine residue within the bHLH region. Thus, all affected probands harbored the E103X mutation. Our ﬁndings suggest
a founder-effect mutation in the MESP2 gene as a major cause of the classical Puerto Rican form of STD/JLS.Congenital vertebral-segmentation abnormalities in hu-
mans are present in a wide variety of rare but well-charac-
terized disorders, as well as in many diverse and poorly un-
derstood phenotypic patterns.1 In some cases, patients
with congenital scoliosis and chest-wall abnormalities
present a major surgical challenge. In 1938, Jarcho and
Levin described a Puerto Rican family whose two children
presented with a shortened trunk, with abnormal segmen-
tation throughout the vertebral column and irregularly
aligned ribs, but with normal long bones and skull.2 Since
then, the authors’ names have frequently been used epon-
ymously (and often inappropriately) for almost any form
of costovertebral malformation.
Spondylothoracic dysostosis (STD) has been well charac-
terized as an autosomal-recessive disorder with high preva-
lence in the Puerto Rican population, comprising 49% of
the STD cases reported in the medical literature.3 The same
phenotype has also been described in other patient popula-
tions.4–11 Patients with STD exhibit a short stature due to
multiple defects in vertebral segmentation and spine forma-
tion, an increased antero-posterior (AP) thoracic diameter,
and, radiologically, a characteristic ‘‘crab-like’’ appearance
of the thoracic cage onAPprojection. The ribs are fused pos-
teriorly at the costovertebral junctions. The short spine and
thoracic cage frequently cause respiratory insufﬁciency,
with a mortality rate of 32% during early childhood.3
The characteristic, periodic vertebral arrangement of the
spine is established during embryogenesis when the verte-1334 The American Journal of Human Genetics 82, 1334–1341, Junbral precursors, the somites, are rhythmically produced
from the presomitic mesoderm in the embryo.12 This strik-
ing rhythmicity, observed in vertebrate model species, of
the somite formation in the presomitic mesoderm results
from the periodic activation of the Notch-, FGF-, and
Wnt-signaling pathways by a molecular oscillator called
the segmentation clock.12,13 The study of nonsyndromic,
Mendelian forms of spondylocostal dysostosis (SCD; re-
ferred to as SCDO by OMIM) has resulted in an increased
understanding of the causes of abnormal vertebral seg-
mentation in humans. Three major SCD subtypes have
been characterized thus far and include: (1) SCDO type 1
(SCDO1 [MIM 277300]), which appears to be the most
common form and is due to a mutation of the delta-like 3
gene (DLL3 [MIM 602768]);14–16 (2) SCDO2 ([MIM
608681]), which is due to a mutation of the mesoderm pos-
terior 2 homolog gene (MESP2 [MIM 605195]);17 and (3)
SCDO3 ([MIM 609813]), which is due to a mutation of
the LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltrans-
ferase gene (LFNG [MIM 602576]).18 All of these genes are
components of the Notch-signaling pathway and are
involved in the segmentation clock.1 Thus, in order to
identify mutations that underlie congenital vertebral
anomalies in humans, we adopted a candidate-gene ap-
proach and sequenced genes associated with somitogene-
sis in patients with congenital scoliosis.
We selected ﬁve genes, DLL3; LFNG; MESP2; hairy and
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Table 1. PCR Primers and Summary of Mutations Identified in Patient Samples
Gene-Exon Annealing Temp.
PCR Primers (50/30)
Product Size (bp) Nonsynonymous SNPsForward Reverse
MESP2-Ex1 55 GACACCTCTCTGCAACCTG CCTGGAGTAGATAAGCTGGG 1117 A66G, E103X
MESP2-Ex2 60 CCAGCCATACCATGGCAAC CCAAGCTACAGGACTGATTC 408 P351H
DLL3-Ex1 60 TCAGATATAAGGCTTGGAAGC TCCCCAGGACCTTCAGGTCG 208
DLL3-Ex2 55 GCGTGGAAAGGGATGAATGC TTTCGCTGGCAGGGTTAGGC 465 A115T
DLL3-Ex3 60 CTCCATTCCTGAACTCTGGC CACCAACCCCGTGTCTCACG 208
DLL3-Ex4 55 TCCGTATGCATCCATGTTCG ATACATCCGCAGCAGTCAGC 493 L142Q, F172C
DLL3-Ex5 55 GCCTCAGTTTCCCTATCTGT GATCCCAAATCTCCAACCTAT 749 L218P
DLL3-Ex6 65 CTTGAGACTGGACAAGGAGC AACCCTGGACTGTCTGAGCC 396
DLL3-Ex7 55 CAGAGCTGGGAAACAGCGCG CCAGCAGCGCAAGGCGTTCG 695
DLL3-Ex8 60 TTGGCCCGATTCCTTGATGC AAAGAGAAGATGGCAGGTAGC 435
Hes7-Ex1 60 TTCTGGCTCCTGGAGTTCTGG GCAGAATCTGGATGTCGAAGGG 294
Hes7-Ex2 55 GCCAACCAAGCTTGTGTCCC AGCGGAGAGGGATCGAATGG 340
Hes7-Ex3 55 TTAACCTCGCCTCGGAGCAGAACC ATTTGGTCGCGCGTTCTGTGGG 367
Hes7-Ex4 55 TCCCCAACACCTGCTCGCC CTCCCTCTTTCCGTCCATCTGG 699
LFNG-Ex1 55 GGTGCTGCGCTGCTGGACTGC ACTGGCGTCGCCCACAGATG 666 G38R
LFNG-Ex2 65 AAACCAAGGCCCGGAGAAGG TGAGTAAACTGCCCTCCCTGTCC 319
LFNG-Ex3&4 65 GGAAAAAGCTGCCTGAATGGG ACTCCGGGTGTGCGCTCC 632
LFNG-Ex5 65 ATGGAGCGGGTCAGCGAGAA AGAGTCCTGCCGGATGGTGC 480
LFNG-Ex6 65 AGATTCCCTCCACAGAGAGCCACG CAGTGAAGAGAAGAGACGGCAGG 581
LFNG-Ex7 60 AGTTTGGGACCTTATTCCTGGG ATGCCGCTTAGAGAGACCCTGC 341 V346M
LFNG-Ex8 65 AAATGGGAGCTCAGCACCTGCC AGAGGCACATAAGTGGCGCTGG 351
PSEN1-Ex3 65 TCTGGGAGCCTGCAAGTGAC CTGTGTCCTCCAGCAATCAGC 463
PSEN1-Ex4 65 TGACGGGTCTGTTGTTAATCC CCCCTCGCTCTCTCAACTG 496
PSEN1-Ex5 65 GAGTTGGGGAAAAGTGACTTA TGAGCCTGGCATTACACA 474
PSEN1-Ex6 55 GGCGAAACCCTGTCTCTACTA GGAGCAACAGAAGAATGTCTC 511
PSEN1-Ex7 55 GCCGTGATTGCACCACTTTAC CATGCCCAGCCGAAATCT 653
PSEN1-Ex8 60 ACCCCAGTAACGATACACT GAATCAACATCAGGTAGAAGA 552
PSEN1-Ex9 60 GGAAGACTGGCGATTTG TGTATTTACTGGGCATTATCA 329 E318G
PSEN1-Ex10 60 GGCCAGCTAGTTACAATG CCAAATAAAAGTTACATGTGA 407
PSEN1-Ex11 65 AACACAGCTGAAGCCTAATTT AGCTCCCAAGTGATTCTAATG 453
PSEN1-Ex12 60 TGCATAATGAACCCTATGAAA ACAGTCCACTGCGATGAA 584(PSEN1 [MIM 104311]), on the basis of their known associ-
ationwith SCD and/or theirmousemutant phenotypes.19–21
The coding frame of these ﬁve genes was ﬁrst sequenced
in a cohort of 31 patients from the Children’s Hospital Bos-
ton, all of whom exhibited various degrees of congenital
scoliosis with abnormal segmentation. The study was ap-
proved by the appropriate Institutional Review Boards
(IRBs), and informed consent was obtained from all hu-
man subjects at the Children’s Hospital Boston. Informed
consent was also obtained from hospitals in Puerto Rico
as described previously (see ref. 3).
Genomic DNA from patient blood samples was prepared
with a PAXgene Blood DNA kit according to the manufac-
turer’s protocol (PreAnalytiX, a QIAGEN/BD company).
Polymerase chain reaction (PCR) was performed with
25 ng of genomic DNA, 0.6 mM primers, 0.5 units Biolace
Taq polymerase (Bioline), 2.0 mM MgCl2, and standard
PCR buffer. For products that were difﬁcult to amplify,
0.6 units of failsafe enzyme (Epicenter) were used in place
of the Biolace Taq polymerase and failsafe buffers H, J, and
D were used for the PCR reaction (reaction details available
upon request). The reactions were then ampliﬁed via the
following thermocycler protocol: 5 min at 95C, 403
(30 s at 95C, 30 s at 60C, and 60 s at 72C), 10 min
at 72C. For some of the primer pairs, the annealing stepThe Amwas performed at 55C or 65C (Table 1). The PCR products
were puriﬁed with ExcelaPure 96-well UF PCR Puriﬁcation
plates (Edge Biosystems) and sequenced with BigDye v3.1
chemistry on a 3730 DNA Analyzer (Applied Biosystems)
with the primers described in Table 1 plus three additional
primers to coverMESP2 exon 1 (50-AAGATCGAGACGCTG
CGCCT-30, 50-CACTGCAGACTCTCCTCGCT-30, 50-CAAG
GGCAGGGGCAAGGACAG-30); two additional primers to
cover DLL3 exon 4 (50-CCCTCCTTTGCCTGTCCTCG-30,
50-GGGTGAGTGGGTTGTGAGAGGG-30), two additional
primers to cover DLL3 exon 7 (50-GCTGCTACGCCCACT
TCTC-30, 50-TGGGAACTCACACCGCGCT-30), and one
additional primer to cover LFNG exon 8 (50-ACGCACAGG
CACGGCCCTAG-30). Primer speciﬁcity was determined by
blast and electronic PCR. Bioinformatic analysis and
searches of pseudogene databases indicated no possibility
of pseudogenes. Sequences of patient samples were com-
pared to reference sequences in GenBank with SeqScape
v2.5 software (Applied Biosystems).
Ten nonsynonymous, single-nucleotide polymorphisms
(SNPs) were identiﬁed in the patient samples, including
nine missense mutations and one nonsense mutation
(Table 1). Of the nine missense mutations, three were
reported in the public SNP database (DLL3 F172C, dbSNP
ID no. rs8107127; DLL3 L218P, dbSNP ID no. rs1110627erican Journal of Human Genetics 82, 1334–1341, June 2008 1335
Figure 1. Rib and Vertebral Defects in
Patients with Spondylothoracic Dysostosis
(A) Antero-posterior (AP) chest radiograph
of patient 01-022 showing the shortened
vertebral column characteristic of patients
with spondylothoracic dysostosis (STD),
also known as Jarcho-Levin syndrome
(JLS). This patient is from the Boston
area but is of Puerto Rican origin.
(B) AP chest radiograph demonstrating
bilateral rib fusion at the costovertebral
junction with the ribs’ ‘‘crab-like’’ appear-
ance as they fan out from their origins.
(C) Thoraco-abdominal radiograph character-
istic of a patient with STD. The spine is short
but straight (AP projection), and multiple
segmentation abnormalities are evident.
The pedicles of the vertebrae are prominent
(‘‘tramline sign’’). The ribs are fused posteri-
orly at the costovertebral junctions and fan
out, showing a ‘‘crab-like’’ appearance.
(D and E) Thoracic reconstructive CT scans. (D) Axial view of a thoracic vertebra shows both anterior and posterior cleft defects. (E) Vertebrae
without clefts present an increased coronal diameter with a decreased sagittal diameter (sickle-shape vertebra).
(F) Patient with STD homozygous for the E103X mutation shows a thoracic spine measurement of 4.2 cm.
(G) Patient with STD heterozygous for the E103X mutation shows a spine measurement of 7.7 cm.
(H) Reconstructive image of the spinal canal of a patient with STD. Arrowheads indicate the measurement points at the thoracic and lumbar
levels, demonstrating a spinal-canal width of 34.0 mm versus an expected 27.1 mm (patient genotype E103X/E103X).
Panels B–H are films from patients of Puerto Rican origin.and PSEN1 E318G, dbSNP ID no. rs17125721) and six were
previously unreported. It is unclear whether thesemissense
mutations are simple polymorphisms or if they contribute
to the disease phenotype in the patients. In a 12-year-old
female of Puerto Rican origin with a severe form of STD
(atypical, with scoliosis), a tethered spinal cord, andmalro-
tation of the right kidney (Figure 1A), we identiﬁed a previ-
ously unreported homozygous nonsense mutation in the
MESP2 gene. This patient harbored a single-base-pair substi-
tution mutation (c.307G/T) in the basic helix-loop-helix
(bHLH) domain of the MESP2 gene (base-pair numbering
based on accession no. BC111413). The mutation resulted
in the replacement of a glutamic acid codon (GAG) at
position 103 with a stop codon (TAG) and the creation of
an SpeI restriction-enzyme site (Figures 2A and 2B). The
mutation, E103X (p.Glu103X), occurs in exon 1 in the
middle of the bHLH domain and is likely to produce a
truncated nonfunctional protein and to be susceptible to
nonsense-mediated RNA decay (NMD)22 (Figure 2C).
Because of the Puerto Rican origin of the patient and the
high frequency of STD in the Puerto Rican population, we
sequenced the MESP2 gene in a cohort of 14 Puerto Rican
patients with STD. We ﬁrst examined the MESP2 gene in
ten Puerto Rican probands and family members previously
reported.3 Eight of the ten probands were homozygous for
the E103Xmutation (Table 2). The unaffected parents were
heterozygous carriers. An additional patient (0600905-01)
was heterozygous for the E103X mutation and an L125V
(c.373C/G,p.Leu125Val)missenseMESP2mutation(Table2).
The L125V mutation occurs in a conserved leucine residue1336 The American Journal of Human Genetics 82, 1334–1341, Junein the bHLH domain (Figure 2D) and is predicted to be del-
eterious by the Sorting Intolerant From Tolerant (SIFT)
prediction program23 but predicted to be neutral by the
PMUT algorithm.24 The L125V mutation was not present
in a panel of ethnically matched controls, suggesting
that the L125V mutation is not a common polymorphism
in the Puerto Rican population (n ¼ 24, data not shown).
The other patient (000408-05) was heterozygous for the
E103X mutation, but a second MESP2 mutation was not
identiﬁed, nor was there any mutation in the DLL3 or
LFNG genes (data not shown). It is unclear how the
E103X mutation contributes to the STD phenotype in
this particular patient. The father of this patient was of
Puerto Rican and Chinese ethnicity, which could explain
the lack of a second MESP2 gene mutation. It is possible
that this patient has a partial gene deletion or a mutation
in the promoter or regulatory region, given that only
coding exons and exon/intron junctions were sequenced.
Alternatively, this patient might carry a mutation in an
as-yet-unidentiﬁed gene. Two variants of the MESP2
gene—A66G and S220F—were identiﬁed in two parental
carriers (Table 2) and were believed to be polymorphisms,
given that these variants were not transmitted to their af-
fected offspring.
The MESP2 gene was sequenced in two other affected
families of Puerto Rican origin (Figures 3A and 3B), for
whom radiographs were unavailable. The two probands
of these families were homozygous for the E103X muta-
tion. Unexpectedly, however, two affected third cousins
of the proband in one of these families (Figure 3B) were2008
Figure 2. Detection of the E103X Mutation by DNA Sequencing and Restriction Fragment Length Polymorphism (RFLP) Analysis
(A) The amino acid and DNA sequences (top, orange) of MESP2 from GenBank are compared with the sequences from the patient with
STD/JLS. The single-base-pair substitution mutation (c.307G/T) is indicated by a vertical box. The asterisk indicates the stop codon.
(B) The c.307G/T mutation results in the addition of an SpeI site, which can be detected as an RFLP. Sample no. 01021 is from a control
patient who does not have the E103X mutation. Sample no. 01022 is from a patient who is homozygous for the E103X mutation.
(C) Comparison of MESP2 full-length protein versus truncated protein caused by the E103X mutation. The full-length MESP2 protein (top)
has an N-terminal (N-term) domain followed by a basic helix-loop-helix domain (bHLH), a region rich in glycine and glutamine residues
(GQ repeats), and a c-terminal (c-term) region. Between the bHLH domain and the GQ repeats is a conserved CPXCP motif. The predicted
protein resulting from the E103X mutation (bottom) has a short, truncated bHLH domain and is missing the other domains.
(D) Sequence comparison of the bHLH domain of MESP2 to other bHLH proteins. The asterisk indicates the L125V mutation in patient
0600905-01. Identical residues are highlighted in yellow, conserved residues are highlighted in blue, and blocks of similar residues
are highlighted in green. Swiss-Prot accession numbers for the sequences are: human MESP2, Q0VG99; human MESP1, Q9BRJ9; mouse
Mesp2, O08574; human Twist1, Q15672; human Myogenin, P15173; human HEN1, Q02575; mouse dHAND, Q9EPN2; Xenopus Thylacine1,
O73623; Xenopus Thylacine2, O73624; mouse Neurogenin-2, P70447; and Drosophila AS-C/T5, P10083.compound heterozygotes for E103X and a second non-
sense mutation, E230X. This mutation (c.688G/T) results
in the replacement of glutamic acid at position 230 with
a premature termination codon (p.Glu230X). Heterozy-
gous carriers were unaffected.
To determine whether these mutations are responsible
for the phenotype, transcriptional activities of MESP2
variantswere analyzedwith luciferase reporter assays. Previ-
ous studies in mouse revealed that Mesp2 exhibits synergy
with Notch signaling to activate transcription from an Lfng
reporter in cultured cells.25 We conﬁrmed that the human
MESP2 also retained similar activity on the mouse Lfng
reporter, albeit weaker than the mouse Mesp2 protein
(Figure 4A). For the luciferase reporter assays, a 2.5Kb
EcoRI-NotI fragment of the mouse Lfng enhancer was
cloned upstream of luciferase in the pGL4.10 vector (Prom-
ega, Madison, WI, USA). The reporter was transfected into
NIH 3T3 cells with or without constructs expressing the
Notch intracytoplasmic domain (NICD) fused to the venus
variant of the yellow ﬂuorescent protein (YFP) (50 ng) andThe Amone of the following: 3 3 Flag-tagged mouse Mesp2
(50 ng), human MESP2 (50 ng), human MESP2 E103X (50
ng), human MESP2 500-503 dup (50 ng) or human MESP2
L125V (50 ng). In this assay the NICD-YFP expression
construct acts as a constitutively active Notch receptor.
pGL4.74 (Promega)was cotransfected as an internal control
(10 ng) to normalize for differences in transfection efﬁ-
ciency. After 36 hr, luciferase activities were measured
with a Dual Luciferase Assay kit (Promega), and the activi-
ties shown in Figure 4B represent average values, obtained
fromat least three independent experiments.We examined
three different MESP2 mutant cDNA constructs harboring
two mutations reported in this paper, E103X and L125V,
as well as the 4-bp duplication (c.500–503 dupACCG) re-
portedpreviously.17 The results indicate that all threemuta-
tions lack transcriptional activities in this assay (Figure 4B).
We compared the genotypes of ten patients with STD
with their respective clinical phenotypes and natural histo-
ries. The two patients who died during early infancy were
homozygous for the E103X mutation, but fewer clinicalerican Journal of Human Genetics 82, 1334–1341, June 2008 1337
measurements and data were available for them. Clinical
data are summarized in Table 3, and representative images
of the skeletal defects are presented in Figures 1B–1H. Axial
skeletal dimensions were compared to normal standards.26
Phenotypical data suggest that heterozygosity for the
E103X mutation produces a milder phenotype in terms
of the thoracic measurements (Figures 1F and 1G), al-
though due to the small sample size the differences were
not statistically signiﬁcant.
We have shown that homozygosity for theMESP2 E103X
mutation causes STD/JLS and is a common gene mutation
in Puerto Rican patients, highly suggestive of a founder
effect. Furthermore, we discovered two additional mu-
tations—E230X and L125V—that are predicted to alter
MESP2 function. The E230X mutation causes a premature
stop codon in the c-terminal domain, and the L125Vmuta-
tion destroys a conserved leucine residue in the bHLH do-
main. This suggests that multiple mutations in MESP2, in-
cluding compound heterozygosity, can give rise to a wide
range of vertebral phenotypes ranging from SCDO21,17 to
STD. Whereas MESP2 is located on chromosome 15q26.1,
Table 2. MESP2 Mutations in Patients of Puerto Rican Origin
Family








1 Proband 990706-01 AF Hom
1 Parent 990706-03 OC Het
1 Parent 990706-04 OC Het
2 Father 980615-01 OC Het
2 Mother 980615-03 OC Het
2 Proband 980615-04 AF Hom
3 Proband 980524-01 AF Hom
3 Father 980524-03(A) OC Het
3 Mother 980504-04B OC Het
4 Proband 980712-01 AF Hom
4 Parent 980712-02 OC Het A66G
(Het)
4 Parent 980712-03 OC Het
5 Proband 000308-01 AF Hom
5 Parent 000308-02 OC Het
6 Proband 980507-01 AF Hom
6 Parent 980725-02 OC Het
7 Proband 990617-01 AF Hom
7 Parent 990602-02 OC Het
8 Proband 000201-01 AF Hom
8 Parent 000201-03 OC Het
8 Parent 000201-02 OC Het
9 Proband 0600905-01 AF Het L125V
(Het)




9 Parent 0600905-03 OC Het
10 Proband 000408-05 AF Het
10 Parent 000408-07 OC WT
10 Parent 000427-02 OC Het
AF denotes affected, OC denotes obligate carrier, Hom denotes homozy-
gous, Het denotes heterozygous, and WT denotes wild-type.1338 The American Journal of Human Genetics 82, 1334–1341, Juninitial homozygosity linkage-mapping studies using a pool-
ing technique showed linkage to chromosome 2 in some of
the patients included in this study.27 However, included in
the initial pooling analysis was a subgroup of patients who,
after review of their radiographs, did not meet the clinical
criteria for the STD/JLS phenotype.
These different phenotypes associated withmutations in
the same gene might be explained by the position and ef-
fect of the mutation. The E103X and E230X mutations
identiﬁed in patients with STD are located within the ﬁrst
exon of the MESP2 gene, and the resulting mutant mRNA
transcripts are predicted to be susceptible to NMD.22
Therefore, patients homozygous or compound heterozy-
gous for these mutations are likely to have a reduced or
absent MESP2 protein. However, the 4 bp duplication
identiﬁed in a small consanguineous family with a milder
form of SCD,17 which includes less-severe segmentation
abnormalities and misaligned ribs than those observed in
patients with SCDO1, occurs after the bHLH domain in
exon 1 and causes a frameshift that results in a premature
stop codon within the second and ﬁnal exon of MESP2.
Transcripts carrying this mutation would not be subject
to NMD. In these patients, a truncated protein containing
an intact bHLH domain, which could retain some func-
tion, is predicted. However, in the luciferase assay, the
E103X, L125V, and 500–503 dup mutations all have a
similar impact on MESP2 activity. Therefore, synergy
with the Notch intracellular domain for control of the
activation of speciﬁc targets is likely to be similarly altered
in these mutants, but other functions are likely to be intact
in the 500–503 dup mutation, thus potentially accounting
for the milder phenotype observed.17
Our phenotypic data suggest that homozygosity for the
E103X mutation gives rise to a more severe phenotype
than does compound heterozygosity involving this muta-
tion (according to thoracic measurements). Results from
pulmonary-function tests of patients heterozygous for
E103X should show a less-restrictive pattern than do
results from those who are homozygous. In this study,
thoracic CT scans had not been performed on the E103X
homozygous patients who died; thus, comparison with
homozygous E103X survivors was not possible.
The discovery of three deleterious MESP2 mutations in
a single population is unusual and could suggest a posi-
tive-selection pressure or heterozygous advantage as de-
scribed in other disorders such as Cystic Fibrosis (CF [MIM
219700]) and Sickle Cell Anemia (MIM 603903).28,29 How
frequent theMESP2mutations are in the general Puerto Ri-
can population andhowheterozygosity for suchmutations
could be beneﬁcial remain unclear. Future studies will focus
on sequencing MESP2 in a larger sample size to determine
allele frequency in the Puerto Rican population. Re-evalua-
tion of mice heterozygous for Mesp2 knockout mutations
might also provide clues to a possible mechanism for
positive-selection pressure.
In the mouse embryo,Mesp2 expression is ﬁrst observed
in the presomitic mesoderm as a stripe which preﬁgurese 2008
the future somite.19 These stripes provide the frame on
which the periodic pattern of the vertebrae in the adult
spine is built. Mesp2 expression subsequently reﬁnes and
becomes localized in the future anterior somitic compart-
ment. The rostrocaudal subdivision of somites is critical
for the formation of vertebrae, which develop when the
caudal half of one somite fuses to the rostral half of the
next somite during a process called resegmentation.30 Ge-
netic experiments in the mouse have demonstrated that
Mesp2 plays a critical role in the somite-boundary forma-
tion and in the speciﬁcation of the anterior somitic com-
partment.25,31 Knockout of theMesp2 gene results in severe
segmentation defects of the vertebral column, including
proximal fusion of the ribs resembling that observed in pa-
tients with STD.19 Our studies suggest that MESP2 muta-
tions also disrupt somitogenesis in humans, resulting in
STD and SCD. Conservation of the role of MESP2 between
mouse and humans provides further evidence in favor of
the conservation of the segmentation clock and the associ-
ated segmentation machinery in mammals.
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Table 3. Summary of Clinical and Radiological Findings in Affected Subjects
Observation or Measurement Subjects and Findings
Genotypes E103X/E103X (n ¼ 8); E103X/L125V (n ¼ 1); E103X/unknown (n ¼ 1)
Age Deceased (n ¼ 2; 4 mos, 3 mos)
Preschool (n ¼ 2; 2 yrs, 4 yrs)
School-age (n ¼ 4; avg. 12.2 yrs; range: 8–18)
Adults (n ¼ 2; 34 yrs, 35 yrs)
Hospital treatment < 1 yr: 3.7 admissions; avg. length 4.8 days (range: 2–18)
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Lung volumes compared with the
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Note Added in Proof
Very recently, another nonsense mutation in exon 1 of MESP2,
G81X, has been found in a patient with a typical STD phenotype
as described in this paper (P.T., S.E., E.Y.). The affected individual is
of European descent, from Norway, and homozygous for the
mutation. We are grateful to Øivind Braaten and Stefan Kutzsche
(Ulleva˚l University Hospital, Oslo) for bringing this case to our
attention.erican Journal of Human Genetics 82, 1334–1341, June 2008 1341
